Camp4 Therapeutics (CAMP) Accounts Payables (2023 - 2026)

Camp4 Therapeutics' Accounts Payables history runs 4 years deep, the most recent figure standing at $863000.0 for Q1 2026.

• In Q1 2026, Accounts Payables changed N/A year-over-year to $863000.0; the TTM figure through Mar 2026 stood at $863000.0 (changed N/A YoY), while the FY2025 annual figure was $182000.0, down 84.96% from the prior year.
• Accounts Payables came in at $863000.0 for Q1 2026 at Camp4 Therapeutics, up from $182000.0 in the prior quarter.
• In the past five years, Accounts Payables ranged from a high of $3.9 million in Q3 2024 to a low of $182000.0 in Q4 2025.
• A 4-year average of $1.3 million and a median of $1.0 million in 2023 frame the typical range for Accounts Payables.
• Across the five-year window, Accounts Payables advanced 16.12% in 2024 and slumped 84.96% in 2025, its largest moves.
• Camp4 Therapeutics' Accounts Payables stood at $1.0 million in 2023, then gained by 16.12% to $1.2 million in 2024, then plunged by 84.96% to $182000.0 in 2025, then soared by 374.18% to $863000.0 in 2026.
• According to Business Quant data, Accounts Payables over the past three periods registered $863000.0, $182000.0, and $585000.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison